A μ- and κ-opioid receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

Nalmefene (hydrochloride)

Item No. 28266

Technical Information
Formal Name
(5α)-17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-morphinan-3,14-diol, monohydrochloride
CAS Number
58895-64-0
Synonyms
  • NIH 10365
Molecular Formula
C21H25NO3 • HCl
Formula Weight
Purity
≥98%
Formulation
A solid
Acetonitrile: Slightly Soluble: 0.1-1 mg/mlDMSO: Soluble: ≥10 mg/mlWater: Slightly Soluble: 0.1-1 mg/ml
SMILES
O[C@]12[C@]3(CCN(CC4CC4)[C@@H]2C5)[C@](OC6=C3C5=CC=C6O)([H])C(CC1)=C.Cl
InChi Code
InChI=1S/C21H25NO3.ClH/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13;/h4-5,13,16,19,23-24H,1-3,6-11H2;1H/t16-,19+,20+,21-;/m1./s1
InChi Key
GYWMRGWFQPSQLK-OPHZJPRHSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    Nalmefene is an antagonist of μ- and κ-opioid receptors (Kis = 0.91 and 1.03 nM, respectively, in CHO membranes expressing the human receptors).1 It is selective for μ- and κ-opioid receptors over δ-opioid receptors (Ki = 13.26 nM in CHO membranes expressing the human receptors). Nalmefene decreases self-administration of alcohol in non-alcohol- and alcohol-dependent rats.2 It reduces food and water intake and body weight in obese and lean rats when administered at a dose of 25 mg/kg per day.3 Nalmefene (32 mg/kg) inhibits morphine-induced scratching behavior and increases in the latency to tail withdrawal in a warm water tail withdrawal assay in rhesus monkeys.4 Formulations containing nalmefene have been used in the treatment of opioid overdose.

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ghirmai, S., Azar, M.R., Polgar, W.E., et alSynthesis and biological evaluation of α- and β-6-amido derivatives of 17-cyclopropylmethyl-3, 14β-dihydroxy-4, 5α-epoxymorphinan: Potential alcohol-cessation agents. J. Med. Chem. 51(6), 1913-1924 (2008).

    2. Walker, B.M., and Koob, G.F. Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence. Neuropsychopharmacology 33(3), 643-652 (2008).

    3. McLaughlin, C.L., and Baile, C.A. Nalmefene decreases meal size, food and water intake and weight gain in Zucker rats. Pharmacol. Biochem. Behav. 19(2), 235-240 (1983).

    4. Ko, M.C., and Naughton, N.N. An experimental itch model in monkeys: Characterization of intrathecal morphine-induced scratching and antinociception. Anesthesiology 92(3), 795-805 (2000).